Lanlan Xu

138 Tong Zipo Road
Changsha, 410013, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Triple combination of SPR741, clarithromycin, and erythromycin against Acinetobacter baumannii and its tolerant phenotype.

Triple combination of SPR741, clarithromycin, and erythromycin against Acinetobacter baumannii and its tolerant phenotype.

Journal: Journal of applied microbiology

Published: March 23, 2022

SPR741, Double- or Triple-Combined With Erythromycin and Clarithromycin, Combats Drug-Resistant Klebsiella pneumoniae, Its Biofilms, and Persister Cells.

SPR741, Double- or Triple-Combined With Erythromycin and Clarithromycin, Combats Drug-Resistant Klebsiella pneumoniae, Its Biofilms, and Persister Cells.

Journal: Frontiers in cellular and infection microbiology

Published: January 20, 2022

Anti-hepatitis C virus drug simeprevir: a promising antimicrobial agent against MRSA.

Anti-hepatitis C virus drug simeprevir: a promising antimicrobial agent against MRSA.

Journal: Applied microbiology and biotechnology

Published: January 12, 2022

Repurposing Eltrombopag as an Antimicrobial Agent Against Methicillin-Resistant Staphylococcus aureus.

Repurposing Eltrombopag as an Antimicrobial Agent Against Methicillin-Resistant Staphylococcus aureus.

Journal: Frontiers in microbiology

Published: October 07, 2021

A novel bactericidal small molecule, STK-35, and its derivative, STK-66, as antibacterial agents against Gram-negative pathogenic bacteria in vitro and in vivo.

A novel bactericidal small molecule, STK-35, and its derivative, STK-66, as antibacterial agents against Gram-negative pathogenic bacteria in vitro and in vivo.

Journal: Letters in applied microbiology

Published: September 30, 2021

Repurposing Sitafloxacin, Prulifloxacin, Tosufloxacin, and Sisomicin as Antimicrobials Against Biofilm and Persister Cells of Pseudomonas aeruginosa.

Repurposing Sitafloxacin, Prulifloxacin, Tosufloxacin, and Sisomicin as Antimicrobials Against Biofilm and Persister Cells of Pseudomonas aeruginosa.

Journal: Current microbiology

Published: July 15, 2021

Antimicrobial, Antibiofilm, and Anti-persister Activities of Penfluridol Against Staphylococcus aureus.

Antimicrobial, Antibiofilm, and Anti-persister Activities of Penfluridol Against Staphylococcus aureus.

Journal: Frontiers in microbiology

Published: June 19, 2021

Corrigendum: Synergistic Microbicidal Effect of Auranofin and Antibiotics Against Planktonic and Biofilm-Encased S. aureus and E. faecalis.

Corrigendum: Synergistic Microbicidal Effect of Auranofin and Antibiotics Against Planktonic and Biofilm-Encased S. aureus and E. faecalis.

Journal: Frontiers in microbiology

Published: April 13, 2021

Repurposing Candesartan Cilexetil as Antibacterial Agent for MRSA Infection.

Repurposing Candesartan Cilexetil as Antibacterial Agent for MRSA Infection.

Journal: Frontiers in microbiology

Published: March 31, 2021

High-Throughput Identification of Antibacterials Against Pseudomonas aeruginosa.

High-Throughput Identification of Antibacterials Against Pseudomonas aeruginosa.

Journal: Frontiers in microbiology

Published: August 04, 2020

Drug Repurposing: In vitro and in vivo Antimicrobial and Antibiofilm Effects of Bithionol Against Enterococcus faecalis and Enterococcus faecium.

Drug Repurposing: In vitro and in vivo Antimicrobial and Antibiofilm Effects of Bithionol Against Enterococcus faecalis and Enterococcus faecium.

Journal: Frontiers in microbiology

Published: July 03, 2020

Insights into idarubicin antimicrobial activity against methicillin-resistant Staphylococcus aureus.

Insights into idarubicin antimicrobial activity against methicillin-resistant Staphylococcus aureus.

Journal: Virulence

Published: May 20, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026